Search Details

Word: upjohn (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...epic struggle of man against microbe, scientists have won the latest battle, but it remains to be seen which side will win the war. On Tuesday, Pharmacia-Upjohn received FDA approval for the first completely new type of antibiotic in more than 35 years. The medication comes as a welcome weapon in the war on "superbugs," mutated bacteria that, over the generations, have grown immune to the old-standby antibiotics. The new drug, Zyvox, is not a cure-all - it attacks only certain forms of bacteria - but in tests it cured two thirds of the patients with strains of staph...

Author: /time Magazine | Title: New 'Miracle' Antibiotic: But For How Long? | 4/19/2000 | See Source »

...company always struck analysts as something of a black sheep. The Monsanto Company, whose subsidiary Searle makes the wildly successful arthritis drug Celebrex, has been casting around for a merger partner for over a year, and now, executives say, the search is over. Monsanto will merge with Pharmacia & Upjohn, joining the ranks of other mega-merger firms like Astra-Zeneca and Rhone-Poulenc-Hoechst, to form a corporation worth about $52 billion. Why did it take so long for Monsanto to find its mate, and why was Pharmacia willing to take it on? The answers lie in Monsanto's agri...

Author: /time Magazine | Title: The Bride of Frankenfoods | 12/20/1999 | See Source »

...heart of the company's agribusiness. Those inklings of dissent were enough, apparently, to make up executives' minds: They would complete a merger and quickly cut the agribusiness free from the rest of the company, letting it fend for itself. That amputation, execs hope, will leave Monsanto and Pharmacia & Upjohn's pharmaceuticals division to take the market by storm - unhindered by bad publicity...

Author: /time Magazine | Title: The Bride of Frankenfoods | 12/20/1999 | See Source »

Even after marketing Rogaine for the past decade, Pharmacia & Upjohn isn?t posting the profits it should be. According to Monday?s Wall Street Journal, income from Rogaine is slumping behind that of Merck?s Propecia - the market?s other, more powerful anti-baldness drug. It seems that in the course of wooing balding men, Pharmacia & Upjohn has tripped over its own advertising claims: The Rogaine web site boasts that the product is ?medically proven to regrow hair,? while following pages back away from such strong language, focusing instead on various caveats to be kept in mind by prospective users...

Author: /time Magazine | Title: Hair Today, Hair Tomorrow? | 9/20/1999 | See Source »

...Street Journal reports, the makers of Rogaine are putting a new, happy face on their product, pitching it as a preventive measure to men who simply want to hang on to the hair they?ve got. ?Rogaine? trumpet the latest ads, ?Stronger than heredity.? The marketing mavens at Pharmacia & Upjohn may be onto an elemental truth: Men who are worried about losing their hair are far more obsessive about their scalps than men who have actually stared into the shiny face of baldness. And in the ongoing tradition of avoidance, this new marketing tack allows men who harbor dark fears...

Author: /time Magazine | Title: Hair Today, Hair Tomorrow? | 9/20/1999 | See Source »

| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Next